0001179110-20-005127.txt : 20200424 0001179110-20-005127.hdr.sgml : 20200424 20200424212937 ACCESSION NUMBER: 0001179110-20-005127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200422 FILED AS OF DATE: 20200424 DATE AS OF CHANGE: 20200424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howell Kelli Mari CENTRAL INDEX KEY: 0001734485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52024 FILM NUMBER: 20816996 BUSINESS ADDRESS: BUSINESS PHONE: 1-760-431-9286 MAIL ADDRESS: STREET 1: C/O ALPHATEC SPINE, INC. STREET 2: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alphatec Holdings, Inc. CENTRAL INDEX KEY: 0001350653 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 202463898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-431-9286 MAIL ADDRESS: STREET 1: 5818 EL CAMINO REAL CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml FORM 4 - X0306 4 2020-04-22 0 0001350653 Alphatec Holdings, Inc. ATEC 0001734485 Howell Kelli Mari C/O ALPHATEC SPINE, INC. 5818 EL CAMINO REAL CARLSBAD CA 92008 0 1 0 0 EVP, Clinical Strategies Common Stock 2020-04-22 4 A 0 98534 0 A 500549 D On April 22, 2020, issuer granted to the reporting person 98,534 restricted stock units (RSUs), subject to receipt of required approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by at least such number as is necessary to vest all of the awards granted on April 22, 2020. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date; provided, however, that the vesting of 50% of these RSUs is subject to the additional condition that the publicly-traded stock price for the issuer's common stock reaches a 30-day average trading price equal to or above $7.52 per share during the first three years following the grant date. Should the publicly-traded stock price for the issuer's common stock reach a 30-day average trading price at or above $7.52 per share at any time during such three year period, this pricing condition will be satisfied and will terminate. Each RSU represents a contingent right to receive one share of the issuer's common stock. /s/ Kelli M. Howell 2020-04-24